Current approaches to the Institute for Healthcare Improvement's Triple Aim framework have primarily focused on managing chronic conditions. However, cancer risk assessment and genetics is one area in which health systems can become more proactive and achieve a stronger patient experience of care, improve the health of their populations, and reduce the cost of that care.

This white paper demonstrates how genetic cancer risk assessment aligns with healthcare's Triple Aim strategy and how software - like CancerIQ - is necessary to achieve this.